British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome

### 1.1 PURPOSE OF GUIDELINES These guidelines were compiled by a multidisciplinary group at the request of the chairman of the British Society of Gastroenterology's Clinical Services Committee. The prime targets for these guidelines are consultant gastroenterologists, specialist registrars in training, and general practitioners. The purpose is to identify and inform the key decisions to be made in the management of patients thought to have functional diseases of the gut. As these comprise the commonest conditions seen by gastroenterologists, the working party represented a wide spectrum of practitioners in gastroenterology, including gastroenterologists from both district general hospitals and tertiary referral centres, as well as primary care practitioners, psychiatrists, psychologists, and dietitians. ### 1.2 SPECIFIC DIFFICULTIES Compared with producing guidelines for the management of well defined diseases such as peptic ulcer where there is a clear disease entity, an obvious end point, and highly effective treatments, drawing up guidelines for functional gastroenterological disorders has had many difficulties. Clinical trials have been difficult to design as the conditions being treated are highly variable with many possible end points, and most therapies only marginally more effective than placebo. Early trials were difficult to evaluate because of inadequate patient definition so that many questions have yet to be addressed with good quality randomised controlled clinical trials. Most of our recommendations are therefore supported by clinical experience rather than randomised controlled clinical trials. Finally, because functional diseases, although potentially debilitating, are non-fatal there are few uniformly available audit measures such as mortality or survival times by which to judge or compare different treatment regimens in different areas of clinical practice. ### 1.3 PROCESS OF GUIDELINE CREATION The co-chairmen were approached by the chairman of the British Society of Gastroenterology's Clinical Services Committee and invited to form a working party. Members were chosen to be broadly representative of clinicians and academics with a long term interest and publication record in the …

[1]  I. Mena,et al.  Postprandial colonic transit and motor activity in chronic constipation , 1990 .

[2]  K W Heaton,et al.  Defecation frequency and timing, and stool form in the general population: a prospective study. , 1992, Gut.

[3]  L. Melton,et al.  Diagnostic value of the Manning criteria in irritable bowel syndrome. , 1990, Gut.

[4]  A. Williams,et al.  Idiopathic bile acid malabsorption--a review of clinical presentation, diagnosis, and response to treatment. , 1991, Gut.

[5]  R. Milo,et al.  "Prokinetic" treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. , 1991, Journal of clinical gastroenterology.

[6]  G. Krejs,et al.  Chronic diarrhea of unknown origin. , 1980, Gastroenterology.

[7]  Burns Dg.  The risk of abdominal surgery in irritable bowel syndrome. , 1986 .

[8]  P. Whorwell,et al.  Non-colonic features of irritable bowel syndrome. , 1986, Gut.

[9]  D. Jewell,et al.  Food intolerance and the irritable bowel syndrome. , 1989, Gut.

[10]  N. Hovdenak.  Loperamide treatment of the irritable bowel syndrome. , 1987, Scandinavian journal of gastroenterology. Supplement.

[11]  D. Carr-Locke,et al.  Irritable bowel syndrome: can the patient's response to colonoscopy help with diagnosis? , 1992, Digestion.

[12]  S. Fukudo,et al.  Brain-gut response to stress and cholinergic stimulation in irritable bowel syndrome. A preliminary study. , 1993, Journal of clinical gastroenterology.

[13]  H. Wulff,et al.  The significance of lactose malabsorption in the irritable colon syndrome. , 1973, Scandinavian Journal of Gastroenterology.

[14]  A R Zinsmeister,et al.  Medical costs in community subjects with irritable bowel syndrome. , 1995, Gastroenterology.

[15]  T. Burks,et al.  Stress-induced changes in intestinal transit in the rat: a model for irritable bowel syndrome. , 1988, Gastroenterology.

[16]  T. Abell,et al.  Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. , 1994, Gastroenterology.

[17]  N. Chaudhary,et al.  The irritable colon syndrome. , 1963, Clinical radiology.

[18]  Matts Sg.  An assessment of dicyclomine hydrochloride ('Merbentyl') in the irritable colon syndrome. , 1967 .

[19]  M. Farthing,et al.  Abnormal illness attitudes in patients with irritable bowel syndrome. , 1995, Journal of psychosomatic research.

[20]  J. Herrera,et al.  Evaluation of patients who meet clinical criteria for irritable bowel syndrome. , 1994, The American journal of gastroenterology.

[21]  D. Drossman,et al.  Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. , 1982, Gastroenterology.

[22]  J. Svedlund,et al.  CONTROLLED STUDY OF PSYCHOTHERAPY IN IRRITABLE BOWEL SYNDROME , 1983, The Lancet.

[23]  D. Drossman,et al.  Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. , 1988, Gastroenterology.

[24]  A R Zinsmeister,et al.  Prevalence of gastrointestinal symptoms in the elderly: a population-based study. , 1992, Gastroenterology.

[25]  K. Heaton,et al.  How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. , 1991, Gut.

[26]  U. Bengtsson,et al.  Survey of gastrointestinal reactions to foods in adults in relation to atopy, presence of mucus in the stools, swelling of joints and arthralgia in patients with gastrointestinal reactions to foods , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[27]  J. Holl,et al.  Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome. , 1986, Digestion.

[28]  A. Williams,et al.  Idiopathic bile acid malabsorption: long-term outcome. , 1995, European journal of gastroenterology & hepatology.

[29]  O. Nyrén,et al.  Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. , 1995, Gastroenterology.

[30]  P. Wong,et al.  Therapeutic Usefulness of Amitriptyline in Spastic Colon Syndrome , 1982, International journal of psychiatry in medicine.

[31]  J. B. Vancouver,et al.  Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome. , 1990, Gastroenterology.

[32]  B. Imbimbo,et al.  Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome. , 1988, The American journal of gastroenterology.

[33]  J. M. Peterson,et al.  Corticotropin-releasing factor directly mediates colonic responses to stress. , 1987, The American journal of physiology.

[34]  D. Macintosh,et al.  Is rectal biopsy necessary in irritable bowel syndrome? , 1992, The American journal of gastroenterology.

[35]  K. Schütze,et al.  Double‐blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome , 1997, Alimentary pharmacology & therapeutics.

[36]  M. Hongo,et al.  Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome , 1998, Gut.

[37]  J. Misiewicz,et al.  Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome. , 1989, Gut.

[38]  W. Paulus,et al.  A diagnostic score for the irritable bowel syndrome: Its value in the exclusion of organic disease , 1984 .

[39]  H. S. Davis,et al.  A Controlled Study , 1966 .

[40]  J. Rhodes,et al.  Peppermint Oil for the Irritable Bowel Syndrome: A Multicentre Trial , 1984, The British journal of clinical practice.

[41]  J. Kellow,et al.  Symptom provocation in irritable bowel syndrome. Effects of differing doses of fructose-sorbitol. , 1992, Scandinavian journal of gastroenterology.

[42]  M. Levitt,et al.  A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance. , 1995, The New England journal of medicine.

[43]  S. Cohen,et al.  Colonic myoelectric activity in the irritable bowel syndrome. , 1976, Gastroenterology.

[44]  S. Sarin,et al.  Optimum dosage of ispaghula husk in patients with irritable bowel syndrome: correlation of symptom relief with whole gut transit time and stool weight. , 1987, Gut.

[45]  S. Larsen,et al.  A double-blind study of the effect of trimipramine in patients with the irritable bowel syndrome. , 1984, Scandinavian journal of gastroenterology.

[46]  L. Buscail,et al.  French experience of Manning's criteria in the irritable bowel syndrome , 1992 .

[47]  F. Hoehler,et al.  The Effect of Stress on Colon Motor and Electrical Activity in Irritable Bowel Syndrome , 1985, Psychosomatic medicine.

[48]  O. B. Schaffalitzky de Muckadell,et al.  Prevalence of surreptitious laxative abuse in patients with diarrhoea of uncertain origin: a cost benefit analysis of a screening procedure. , 1989, Gut.

[49]  E A Mayer,et al.  Evidence for two distinct perceptual alterations in irritable bowel syndrome , 1997, Gut.

[50]  M. van Blankenstein,et al.  Na+-dependent bile acid transport in the ileum: the balance between diarrhea and constipation. , 1990, Gastroenterology.

[51]  F. G. Rosa,et al.  Management of diarrhoeic type of irritable bowel syndrome with exclusion diet and disodium cromoglycate , 1997, InflammoPharmacology.

[52]  T. Jørgensen,et al.  The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors , 1994, Journal of internal medicine.

[53]  A. Zinsmeister,et al.  Dysmotility of the small intestine in irritable bowel syndrome. , 1988, Gut.

[54]  M. Farthing,et al.  Intestinal transit in anxiety and depression. , 1996, Gut.

[55]  E. Blanchard,et al.  Two-year follow-up of behavioral treatment of irritable bowel syndrome , 1988 .

[56]  R. Spiller,et al.  Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients , 1997, BMJ.

[57]  T. Poynard,et al.  Meta‐analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome , 2001, Alimentary pharmacology & therapeutics.

[58]  M. Merrick,et al.  Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. , 1985, British medical journal.

[59]  S. Truelove,et al.  Comparison of various treatments for irritable bowel syndrome. , 1980, British medical journal.

[60]  L. D. O'Donnell,et al.  Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. , 1992, Gastroenterology.

[61]  N. Talley,et al.  Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study , 1998, Gut.

[62]  K. Heaton,et al.  Towards positive diagnosis of the irritable bowel. , 1978, British medical journal.

[63]  M. Eastwood,et al.  Life events, psychiatric illness and the irritable bowel syndrome. , 1987, Gut.

[64]  J. Vandenbroucke,et al.  Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in The Netherlands and Japan. , 1993, Scandinavian journal of gastroenterology. Supplement.

[65]  J. R. Andersen,et al.  The effect of coarse wheat bran in the irritable bowel syndrome. A double-blind cross-over study. , 1985, Scandinavian journal of gastroenterology.

[66]  P. Openshaw,et al.  Towards positive diagnosis of the irritable bowel. , 1978, British medical journal.

[67]  M. Camilleri,et al.  Hyperventilation alters colonic motor and sensory function: effects and mechanisms in humans. , 1996, Gastroenterology.

[68]  S. Matts.  An Assessment of Dicyclomine Hydrochloride (‘Merbentyl‘) in the Irritable Colon Syndrome , 1967, The British journal of clinical practice.

[69]  D K Sommers.  Clinical economics. , 1993, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[70]  P. Whorwell,et al.  Hypnotherapy in severe irritable bowel syndrome: further experience. , 1987, Gut.

[71]  R. Harvey,et al.  PROGNOSIS IN THE IRRITABLE BOWEL SYNDROME: A 5-YEAR PROSPECTIVE STUDY , 1987, The Lancet.

[72]  N. Read,et al.  Psychological stress and the passage of a standard meal through the stomach and small intestine in man , 1983, Gut.

[73]  A. Riordan,et al.  Management of patients with food intolerance in irritable bowel syndrome: the development and use of an exclusion diet , 1995 .

[74]  E. Guthrie.  Brief Psychotherapy with Patients with Refractory Irritable Bowel Syndrome , 1991 .

[75]  G. Sciarretta,et al.  Absence of histopathological changes of ileum and colon in functional chronic diarrhea associated with bile acid malabsorption, assessed by SeHCAT test: a prospective study. , 1994, The American journal of gastroenterology.

[76]  M. Levitt,et al.  A Comparison of Symptoms after the Consumption of Milk or Lactose-Hydrolyzed Milk by People with Self-Reported Severe Lactose Intolerance , 1995 .

[77]  Sang-mo Kang.  Bowel syndrome. , 1995, Treatment review.

[78]  G. Bleijenberg,et al.  Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome? , 1997, Gut.

[79]  D. Farah,et al.  Specific food intolerance: its place as a cause of gastrointestinal symptoms. , 1985, Gut.

[80]  S. Siegel,et al.  Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. , 1989, Science.

[81]  N. Read,et al.  Psychometric scores and persistence of irritable bowel after infectious diarrhoea , 1996, The Lancet.

[82]  J. Kellow,et al.  Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. , 1987, Gastroenterology.

[83]  K W Heaton,et al.  Functional bowel disorders and functional abdominal pain , 1999, Gut.

[84]  E. Blanchard,et al.  Relaxation training as a treatment for irritable bowel syndrome , 1993, Biofeedback and self-regulation.

[85]  S. Larsen,et al.  The effect of trimipramine in patients with the irritable bowel syndrome. A double-blind study. , 1982, Scandinavian journal of gastroenterology.

[86]  M. Delvaux,et al.  Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Results of a multicentre inquiry , 1997, European journal of gastroenterology & hepatology.

[87]  D. Greenbaum.  Preliminary report on antidepressant treatment of irritable bowel syndrome: comments on comparison with anxiolytic therapy. , 1984, Psychopharmacology bulletin.

[88]  M. Farthing,et al.  Ambulatory small intestinal motility in 'diarrhoea' predominant irritable bowel syndrome. , 1994, Gut.

[89]  A. Taylor,et al.  Two controlled evaluations of multicomponent psychological treatment of irritable bowel syndrome. , 1992, Behaviour research and therapy.

[90]  Tudor Gj.  A general practice study to compare alverine citrate with mebeverine hydrochloride in the treatment of irritable bowel syndrome. , 1986 .

[91]  P. Whorwell,et al.  Irritable bowel syndrome in the gynecological clinic , 1989, Digestive diseases and sciences.

[92]  P. Whorwell,et al.  Gynaecological consultation in patients with the irritable bowel syndrome. , 1989, Gut.

[93]  J. Hipólito,et al.  [Anthropo-analytical relaxation in irritable bowel syndrome: results 40 months later]. , 1987, Schweizerische medizinische Wochenschrift.

[94]  W. Whitehead,et al.  Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. , 1980, Digestive diseases and sciences.

[95]  P. Whorwell,et al.  Double blind study of ispaghula in irritable bowel syndrome. , 1987, Gut.

[96]  C. Holdsworth,et al.  Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea. , 1980, Gastroenterology.

[97]  A. Euler.  FOOD INTOLERANCE: A MAJOR FACTOR IN THE PATHOGENESIS OF IRRITABLE BOWEL SYNDROME , 1983 .

[98]  J. Ritchie.  Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome 1 , 1973, Gut.

[99]  W. Vale,et al.  Stress-induced gastrointestinal secretory and motor responses in rats are mediated by endogenous corticotropin-releasing factor. , 1988, Gastroenterology.

[100]  C. O. Kennedy.  A controlled trial , 1971, British Homeopathic Journal.

[101]  G. Bensi,et al.  Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial. , 1990, Gut.

[102]  A. Dawson,et al.  Functional abdominal pain: further evidence that whole gut is affected. , 1982, British medical journal.

[103]  H. Shepherd,et al.  Bran supplementation in the treatment of irritable bowel sgndrome , 1994, Alimentary pharmacology & therapeutics.

[104]  R. Valori,et al.  Effects of different types of stress and of "prokinetic" drugs on the control of the fasting motor complex in humans. , 1986, Gastroenterology.

[105]  P. Costa,et al.  Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. , 1988, Gastroenterology.

[106]  E. Blanchard,et al.  A controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome. , 1995, Journal of consulting and clinical psychology.

[107]  G. Galatola,et al.  The prevalence of bile acid malabsorption in irritable bowel syndrome and the effect of cholestyramine : an uncontrolled open multicentre study , 1992 .

[108]  M. Kamm,et al.  Biofeedback provides long term benefit for patients with intractable, slow and normal transit constipation , 1998, Gut.

[109]  H. Wulff,et al.  A DOUBLE-BLIND TRIAL OF THE EFFECT OF WHEAT BRAN ON SYMPTOMS OF IRRITABLE BOWEL SYNDROME , 1976, The Lancet.

[110]  N. Read,et al.  Irritable bowel syndrome--post salmonella infection. , 1994, The Journal of infection.

[111]  K. Heaton,et al.  WHEAT FIBRE AND IRRITABLE BOWEL SYNDROME A Controlled Trial , 1977, The Lancet.

[112]  P. Whorwell,et al.  CONTROLLED TRIAL OF HYPNOTHERAPY IN THE TREATMENT OF SEVERE REFRACTORY IRRITABLE-BOWEL SYNDROME , 1984, The Lancet.

[113]  U. Bengtsson,et al.  Double blind, placebo controlled food reactions do not correlate to IgE allergy in the diagnosis of staple food related gastrointestinal symptoms. , 1996, Gut.

[114]  R. Corney,et al.  Physical symptom severity, psychological and social dysfunction in a series of outpatients with irritable bowel syndrome. , 1990, Journal of psychosomatic research.

[115]  L. Munck,et al.  Irritable bowel syndrome--prognosis and diagnostic safety. A 5-year follow-up study. , 1985, Scandinavian journal of gastroenterology.

[116]  E. Guthrie,et al.  A controlled trial of psychological treatment for the irritable bowel syndrome. , 1991, Gastroenterology.

[117]  J. Rhodes,et al.  Treating irritable bowel syndrome with peppermint oil. , 1979, British medical journal.

[118]  A R Zinsmeister,et al.  Epidemiology of colonic symptoms and the irritable bowel syndrome. , 1991, Gastroenterology.

[119]  Y. Taché,et al.  Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function. , 1997, The Journal of pharmacology and experimental therapeutics.

[120]  A. Dawson.  The irritable bowel. , 1984, The Practitioner.

[121]  E A Mayer,et al.  Regional cerebral activity in normal and pathological perception of visceral pain. , 1997, Gastroenterology.

[122]  H. Meshkinpour,et al.  Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. , 1988, Gastroenterology.

[123]  M. Elia,et al.  Abnormal colonic fermentation in irritable bowel syndrome , 1998, The Lancet.

[124]  J. Malagelada,et al.  Release of mast cell mediators into the jejunum by cold pain stress in humans. , 1998, Gastroenterology.

[125]  N. Read,et al.  What is the benefit of coarse wheat bran in patients with irritable bowel syndrome? , 1984, Gut.

[126]  D. Burns.  The risk of abdominal surgery in irritable bowel syndrome. , 1986, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[127]  E. Blanchard,et al.  A multi-component treatment for irritable bowel syndrome , 1987 .

[128]  W. Whitehead,et al.  Tolerance for rectosigmoid distention in irritable bowel syndrome. , 1990, Gastroenterology.

[129]  M. Farthing,et al.  Selective affective biasing in recognition memory in the irritable bowel syndrome. , 1993, Gut.

[130]  A. Dawson,et al.  Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study. , 1987, Gut.

[131]  I. Olubuyide,et al.  A study of irritable bowel syndrome diagnosed by manning criteria in an African population , 1995, Digestive diseases and sciences.

[132]  A. Ruigómez,et al.  Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study , 1999, BMJ.

[133]  G. Dirnberger,et al.  Treatment of the irritable bowel syndrome with Bentyl (dicyclomine hydrochloride). , 1981 .

[134]  F. Creed,et al.  Functional abdominal pain, psychiatric illness, and life events. , 1988, Gut.

[135]  J. Svedlund,et al.  Upper gastrointestinal and mental symptoms in the irritable bowel syndrome. , 1985, Scandinavian journal of gastroenterology.

[136]  M. Farthing,et al.  5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. , 1994, Gut.

[137]  G. Gasbarrini,et al.  Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. , 1995, Scandinavian journal of gastroenterology.

[138]  S. Carpenter,et al.  The clinical significance of focal active colitis , 1997 .

[139]  K. Klein.  Controlled treatment trials in the irritable bowel syndrome: a critique. , 1988, Gastroenterology.

[140]  R. E. Barry,et al.  INDIVIDUAL AND GROUP HYPNOTHERAPY IN TREATMENT OF REFRACTORY IRRITABLE BOWEL SYNDROME , 1989, The Lancet.

[141]  Robert S. Sandler,et al.  Symptom complaints and health care seeking behavior in subjects with bowel dysfunction , 1984 .

[142]  Megan E. Pahmier,et al.  Double Blind , 2001, International Psychogeriatrics.

[143]  S. Fullerton,et al.  Symptom duration in patients with irritable bowel syndrome. , 1996, The American journal of gastroenterology.

[144]  P. Whorwell,et al.  Clinical economics review: irritable bowel syndrome , 1997, Alimentary pharmacology & therapeutics.

[145]  W. Thompson.  Gastrointestinal symptoms in the irritable bowel compared with peptic ulcer and inflammatory bowel disease. , 1984, Gut.

[146]  M. Hotopf,et al.  Why do children have chronic abdominal pain, and what happens to them when they grow up? Population based cohort study , 1998, BMJ.

[147]  W. Whitehead,et al.  Evidence for exacerbation of irritable bowel syndrome during menses. , 1990, Gastroenterology.

[148]  P. Whorwell,et al.  Bran and irritable bowel syndrome: time for reappraisal , 1994, The Lancet.

[149]  R. Spiller,et al.  Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. , 1999, The American journal of medicine.

[150]  S. Truelove,et al.  Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk. , 1979, British medical journal.

[151]  I. Cook,et al.  Patients With Irritable Bowel Have Greater Pain Tolerance Normal Subjects Syndrome Than , 1987 .

[152]  P. Whorwell,et al.  Does routine abdominal ultrasound enhance diagnostic accuracy in irritable bowel syndrome? , 1995, The American journal of gastroenterology.

[153]  P. Nash,et al.  Peppermint oil does not relieve the pain of irritable bowel syndrome , 1986, The British journal of clinical practice.

[154]  M. Camilleri,et al.  Transit through the proximal colon influences stool weight in the irritable bowel syndrome. , 1992, Gastroenterology.

[155]  S. Fullerton,et al.  Symptoms and visceral perception in severe functional and organic dyspepsia , 1998, Gut.

[156]  P. Whorwell,et al.  Symptoms of irritable bowel syndrome in ulcerative colitis in remission , 1983, Gut.

[157]  P. Buisseret,et al.  Food allergy and intolerance in 100 patients---local and systemic effects. , 1980, The Quarterly journal of medicine.

[158]  P. Whorwell,et al.  More accurate diagnosis of irritable bowel syndrome by the use of 'non-colonic' symptomatology. , 1991, Gut.

[159]  C. Tasman‐Jones.  Mebeverine in patients with the irritable colon syndrome: double blind study. , 1973, The New Zealand medical journal.

[160]  G. Sturniolo,et al.  [Irritable bowel syndrome]. , 1988, Giornale di clinica medica.

[161]  E. Zamble,et al.  A controlled behavioral treatment study of Irritable Bowel syndrome , 1989 .

[162]  D. Drossman,et al.  Identification of sub-groups of functional gastrointestinal disorders , 1990 .

[163]  Roger Jones,et al.  Irritable bowel syndrome in the general population. , 1992, BMJ.

[164]  M. Tankeyoon,et al.  Prevalence of irritable bowel syndrome in a non-Western population , 1988, British medical journal.

[165]  M. Lessof.  Food allergy and intolerance. , 1989, Current opinion in immunology.

[166]  Irritable colon syndrome treated with an antispasmodic drug. , 1976, The Practitioner.

[167]  S. Fullerton,et al.  Patient‐perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life , 1997, Alimentary pharmacology & therapeutics.

[168]  N. Read,et al.  Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. , 1983, Gut.

[169]  S. Morley,et al.  Responses of consecutive patients to reassurance after gastroscopy: results of self administered questionnaire survey , 1997, BMJ.

[170]  E. Blanchard,et al.  Cognitive therapy for irritable bowel syndrome. , 1994, Journal of consulting and clinical psychology.